Atlas Trials

Flexible-dose Long-term Extension Study of Lu AF11167 in Patients With Schizophrenia With Prominent Negative Symptoms

Clinical trial NCT03929497 · TERMINATED

Trial details

NCT number
NCT03929497
Sponsor
H. Lundbeck A/S
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2019-04-22
Primary completion
2020-09-01
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.